{'52WeekChange': -0.84178984,
 'SandP52WeekChange': None,
 'address1': '190 Elgin Avenue',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.14,
 'askSize': 800,
 'averageDailyVolume10Day': 242000,
 'averageVolume': 138400,
 'averageVolume10days': 242000,
 'beta': None,
 'beta3Year': None,
 'bid': 2.01,
 'bidSize': 3200,
 'bookValue': 0.067,
 'category': None,
 'circulatingSupply': None,
 'city': 'George Town',
 'companyOfficers': [],
 'country': 'Cayman Islands',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.17,
 'dayLow': 1.9834,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -1.335,
 'enterpriseToRevenue': 2.664,
 'enterpriseValue': 56178800,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.9145428,
 'fiftyTwoWeekHigh': 14.41,
 'fiftyTwoWeekLow': 0.9,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 5734508,
 'forwardEps': -0.06,
 'forwardPE': -33.333336,
 'fromCurrency': None,
 'fullTimeEmployees': 73,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0,
 'heldPercentInstitutions': 0.14034,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/stealthbt.com',
 'longBusinessSummary': 'Stealth BioTherapeutics Corp, a clinical-stage '
                        'biotechnology company, focuses on the discovery, '
                        'development, and commercialization of therapies for '
                        'diseases involving mitochondrial dysfunction. Its '
                        'lead product candidate, Elamipretide, has the '
                        'potential to treat rare genetic and common '
                        "age-related mitochondrial diseases. The company's "
                        'product candidates include SBT-20, a small peptide '
                        'that targets and binds reversibly to cardiolipin, '
                        'stabilizing mitochondrial structure, and function '
                        'under conditions of oxidative stress; and SBT-272, a '
                        'lead discovery pipeline compound, evaluating for rare '
                        'neurodegenerative diseases, such as amyotrophic '
                        'lateral sclerosis. Stealth BioTherapeutics Corp was '
                        'founded in 2006 and is based in George Town, the '
                        'Cayman Islands.',
 'longName': 'Stealth BioTherapeutics Corp',
 'market': 'us_market',
 'marketCap': 98630600,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_49955171',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -44090000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.99,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.33,
 'previousClose': 1.98,
 'priceHint': 4,
 'priceToBook': 29.850746,
 'priceToSalesTrailing12Months': 4.6773176,
 'profitMargins': -2.09086,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.17,
 'regularMarketDayLow': 1.9834,
 'regularMarketOpen': 1.99,
 'regularMarketPreviousClose': 1.98,
 'regularMarketPrice': 1.99,
 'regularMarketVolume': 556227,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 49315300,
 'sharesPercentSharesOut': 0.0001,
 'sharesShort': 18641,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 11344,
 'shortName': 'Stealth BioTherapeutics Corp.',
 'shortPercentOfFloat': None,
 'shortRatio': 0.03,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'MITO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.231,
 'twoHundredDayAverage': 1.9776331,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '45b4218e-ecf8-392b-abd3-24987301f764',
 'volume': 556227,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.stealthbt.com',
 'yield': None,
 'ytdReturn': None,
 'zip': 'KY1-9005'}